Anebulo Pharmaceuticals (ANEB) Institutional Ownership $1.59 +0.07 (+4.61%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)CurrentInstitutional OwnershipPercentage28.40%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$70.89K Get ANEB Insider Trade Alerts Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANEB Institutional Buying and Selling by Quarter Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] Anebulo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/16/2024 LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509% 2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116% 11/10/2022 Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994% 10/14/2022 LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888% 7/22/2022 LVW Advisors LLC700,000$3.64M0.7%N/A2.999% 8/18/2021 Ikarian Capital LLC174,811$1.20M0.1%N/A0.749% 8/17/2021 22NW LP3,343,565$22.80M6.1%N/A14.322% 8/17/2021 Boothbay Fund Management LLC19,835$135K0.0%N/A0.085% 8/13/2021 Laurion Capital Management LP225,000$1.55M0.0%N/A0.964% (Data available from 1/1/2016 forward) ANEB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANEB shares? During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: LVW Advisors LLC ($1.56M), Herr Investment Group LLC ($72K).Learn more on ANEB's institutional investors. What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors? 28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings. Which institutional investors have been buying Anebulo Pharmaceuticals stock? The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: Herr Investment Group LLC ($29.64K). How much institutional buying is happening at Anebulo Pharmaceuticals? Institutional investors have bought a total of 29,644 shares in the last 24 months. This purchase volume represents approximately $71.85K in transactions. Which Anebulo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($29.29K). How much institutional selling is happening at Anebulo Pharmaceuticals? Institutional investors have sold a total of 29,292 shares in the last 24 months. This volume of shares sold represents approximately $70.89K in transactions. Related Companies Tonix Pharmaceuticals Major Shareholders OptiNose Major Shareholders Sol-Gel Technologies Major Shareholders Atossa Therapeutics Major Shareholders Eledon Pharmaceuticals Major Shareholders Organigram Major Shareholders Tenaya Therapeutics Major Shareholders Checkpoint Therapeutics Major Shareholders Skye Bioscience Major Shareholders Adaptimmune Therapeutics Major Shareholders This page (NASDAQ:ANEB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
